grifols biomat compensation

Reuters: Grifols to seek compensation from Gotham at least equivalent to share loss - board member BARCELONA, Jan 10 (Reuters) - Spain's pharmaceutical company Grifols (GRLS.MC), opens new tab will seek a compensation at least equivalent to the share price loss prompted by short seller Gotham City ... Grifols to seek compensation from Gotham at least equivalent to share loss - board member Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives.

Understanding the Context

Descubre las innovadoras soluciones biofarmacéuticas y sanitarias integrales de Grifols centradas en el paciente. Explore Grifols Poland, a leader in biotechnology and healthcare, dedicated to improving patient lives through innovative therapies and high-quality services. Grifols is a global healthcare company that has enhanced the health and well-being of people around the world. Join Grifols to create a lasting impact with your career.